Zanubrutinib
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Patient Power
ASH: COVID-19 Resources for Managing Blood Cancers
Leukemia & Lymphoma Society
CLL Society